OSTN and sarcopenia: Therapeutic overexpression of Musclin in skeletal muscle might also be beneficial in patients: Musclin (OSTN) mRNA levels in skeletal muscle biopsies from patients suffering from heart failure and sarcopenia or cachexia were markedly downregulated.